Starten Sie Ihre Suche...


Wir weisen darauf hin, dass wir technisch notwendige Cookies verwenden. Weitere Informationen

Forschungszentrum für Immuntherapie (FZI)

Forschungsschwerpunkt / Johannes Gutenberg-Universität Mainz

Publikationen
Ergebnisse pro Seite:  10

Bumma, Naresh; Richter, Joshua; Jagannath, Sundar et al.

Linvoseltamab for Treatment of Relapsed/Refractory Multiple Myeloma (vol 42, pg 2702, 2024)

JOURNAL OF CLINICAL ONCOLOGY. Bd. 42. H. 33. 2024 S. 4001-4001


Schraad, Muriel; Runkel, Stefan; Hitzler, Walter et al.

Long-Term Observation of SARS-CoV-2 Vaccination Response upon High Efficacy Treatment in Multiple Sclerosis-A Real-World Scenario

VACCINES. Bd. 12. H. 3. 2024


Protopapa, Maria; Schmaul, Samantha; Schraad, Muriel et al.

Lower leukocytes pretreatment as a possible risk factor for therapy-induced leukopenia in interferon-beta-treated patients with multiple sclerosis

THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS. Bd. 17. 2024



Schaller-Paule, Martin A.; Maiworm, Michelle; Schaefer, Jan Hendrik et al.

Matching proposed clinical and MRI criteria of aggressive multiple sclerosis to serum and cerebrospinal fluid markers of neuroaxonal and glial injury

JOURNAL OF NEUROLOGY. Bd. 271. H. 6. 2024 S. 3512-3526


Ruecker, Frank G.; Bullinger, Lars; Cocciardi, Sibylle et al.

Measurable residual disease monitoring in AML with <i>FLT3</i>-ITD treated with intensive chemotherapy plus midostaurin

BLOOD ADVANCES. Bd. 8. H. 23. 2024 S. 6067-6080


Chen, Zhao; Xing, Fei; Yu, Peiyun et al.

Metal-organic framework-based advanced therapeutic tools for antimicrobial applications

ACTA BIOMATERIALIA. Bd. 175. 2024 S. 27-54


Tito, Raul Y.; Verbandt, Sara; Vazquez, Marta Aguirre et al.

Microbiome confounders and quantitative profiling challenge predicted microbial targets in colorectal cancer development

NATURE MEDICINE. Bd. 30. H. 5. 2024 S. 1339-1348


Kattimani, Yogita M.; Waisman, Ari

Microglia's heroic battle against neurodegeneration

NEURON. Bd. 112. H. 16. 2024 S. 2661-2663